期刊文献+

HPV16阳性宫颈非典型增生和浸润性宫颈癌组织中E6变体的研究 被引量:2

A Study on Human Papillomavirus 16 E6 Variants Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
暂未订购
导出
摘要 通过检测 E6变体在 HPV16阳性的宫颈非典型增生 (CIN)和宫颈浸润癌 (ICC)患者中的分布 ,研究其致癌能力。方法 :用 PCR和双脱氧终止荧光法检测了 42例 E6基因点突变及其编码氨基酸改变 ,统计分布差异。结果 :2例 (5 % )为原型 ,40例 (95 % )的 E6 DNA序列中含有 1至 3个点突变 ,导致 13类 E6氨基酸残基改变 ,组合成 17种 (94% ) HPV16变体。出现频率较高的 4种变体在 CIN和 ICC病例中共同存在 ,分布无显著性差异(P>0 .0 5 )。DNA的点突变数在 CIN和 ICC病例中的分布也无显著性差异 (P>0 .0 5 )。结论 :HPV16 E6的变体多于原型 ,但是变体和原型的致癌能力没有明显差别。 This study sought to clarify whether HPV16 E6 variants are obviously more oncogenic than the prototype by detecting the frequencies of E6 variants in both cervical intraepithelial neoplasia(CIN) and invasive cervical carcinoma(ICC). 42 patients with CIN or ICC and HPV16 positive were selected and investigated for the E6 genes for mutations. PCR amplified products were sequenced by the fluorescent dideoxy termination method. Frequencies of E6 variants and prototype were analyzed for differences in both CIN and ICC The results showed that 40(95%) patients harbored one to three point mutations of E6 gene and only two (5%) patients harbored the prototype. Of 14 kinds of point mutation, 13 led to amino acid residue substitution. The residue substitutions of high frequency were aspartate 25 glutamic acid (i.e. substitution of amino acid in position 25 with a change from aspartate to glutamic acid, the same below), Leucine 83 Valine,Glutamic acid 113 Aspartate and Leucine 115 Proline. These residue substitutions existed in both CIN and ICC.No significant difference in the distribution of these residue substitutions was noted between CIN and ICC ( P >0.05). In addition no significant difference in the distribution of the number of DNA mutation was observed between CIN and ICC ( P >0.05). Otherwise, seven kinds of residue substitution were of low frequency. Of them, two and five existed in CIN and ICC respectively. Since a patient harbored zero to three residue substitutions, these 13 kinds of residue substitution created 17 types of E6 variants. These result indicate that HPV16 E6 variants are more prevalent than the prototype. There is no significant difference in the distribution of E6 variants of high frequency between CIN and ICC, suggesting that the E6 variants do not generate significant difference in their carcinogenesis.
出处 《华西医科大学学报》 CSCD 2000年第4期511-514,共4页 Journal of West China University of Medical Sciences
关键词 HPV16 E6变体 宫颈非典型增生 宫颈浸润癌 HPV16 E6 variant Carcinogenicity
  • 相关文献

参考文献1

二级参考文献10

  • 1阮力 汪垣 等.新型疫苗的研究与展望[M].北京:学苑出版社,1992..
  • 2Stoler MH. Human papillomavirus and cervical neoplasia: a model for carciogenesis. Int J Gynecol Pathol,2000,19: 16-28.
  • 3De Bruijn MLH, Greenstone HL, Vermeulen H, et al. L1-spicific protection from tumor challenge elicited by HPV 16 virus-like particles. Virology, 1998, 250:371-376.
  • 4Marais D, Passmore JA, MacleanJ, et al. A recombinant human papillomavirus(HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles. J Gen Virol, 1999, 80:2471-2475.
  • 5Schiller JT. Papillomavirus-like particle vaccines for cervical cancer.Mol Med Today, 1999, 5:209-215.
  • 6Ji H, Wang TL, Chen CH, et al. Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. Hum Gene Ther,1999,10:2727-2740.
  • 7Sarkar AK, Tortolero-Luna G, Nehete PN, et al. Studies on in vivo induction of cytotoxic T lymphocyte responses by synthetic peptides from E6 and E7 oncoproteins of human papillomavirus type 16. Viral Immunol, 1995,8:165-174.
  • 8马海伦,孙朝晖,陆柔剑,娄元梅,郭斐,张帆,阮力.同时表达多种外源基因的非复制型重组痘苗病毒的构建[J].病毒学报,1999,15(1):21-28. 被引量:16
  • 9骆卫峰,韩立群,任皎,田厚文,陆振华,谷淑燕,阮力.人乳头瘤病毒16型E6和E7基因及其突变体转化活性的研究[J].病毒学报,2002,18(2):97-101. 被引量:16
  • 10韩立群,任皎,梁雨,田厚文,职慧军,骆卫锋,陆振华,魏兰兰,阮力.表达HPV16型结构蛋白的非复制型重组痘苗病毒的构建与鉴定[J].中华实验和临床病毒学杂志,2002,16(3):256-260. 被引量:7

共引文献1

同被引文献5

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部